What is Hyperfine Inc (HYPR) stock price today?

Hyperfine Inc (HYPR) currently trades at $1.87 per share. The stock has a market capitalization of $163.54M and a P/E ratio of —x.

Is HYPR stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Hyperfine Inc has a Smart Value Score of 25/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is -4.95.

What is Hyperfine Inc's revenue and earnings?

Hyperfine Inc has trailing twelve-month (TTM) revenue of $13.56M with profit margins of -262.30%. Earnings per share (EPS) is $-0.43.

Is Hyperfine Inc financially healthy?

Hyperfine Inc's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of -4.95 places it in the distress.

HYPR

Hyperfine Inc

NASDAQ: HYPR · HEALTHCARE · MEDICAL DEVICES

$1.87

+12.65% today

Updated 2026-05-01

Market cap

$163.54M

P/E ratio

—

P/S ratio

12.06x

EPS (TTM)

$-0.43

Dividend yield

—

52W range

$1 – $2

Volume

0.6M

Market cap

$163.54M

P/E ratio

—

P/S ratio

12.06x

EPS (TTM)

$-0.43

Dividend yield

—

52W range

$1 – $2

Volume

0.6M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

8.0

Growth

5.3

Quality

C+

2.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

-5.0

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →205 stocks currently score above 75

Price targets

Analyst target

$2.05

+9.63%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 128.00% QoQ

Risks

- Piotroski 3/9 — weak financial health

- Altman Z -4.95 — distress zone

- Thin margins at -262.30%

- Negative free cash flow $-5.27M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$6.81M	$11.03M	$12.89M	$13.56M	$13.56M
Net income	$-73.16M	$-44.24M	$-40.72M	$-35.57M	$-5.91M
EPS	—	—	—	—	$-0.43
Free cash flow	$-72.92M	$-42.61M	$-39.15M	$-29.13M	$-5.27M
Profit margin	-1,073.73%	-401.00%	-315.90%	-262.29%	-262.30%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
HYPR	$163.54M	25	8.0	2.0	5.0	5.3	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-41.61%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-26.29%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.35%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Hyperfine Inc trades at $1.87. Our Smart Value Score of 25/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -4.95, it sits in the distress. TTM revenue stands at $13.56M. with profit margins at -262.30%.

Frequently asked questions

What is Hyperfine Inc's stock price?

Hyperfine Inc (HYPR) trades at $1.87.

Is Hyperfine Inc overvalued?

Smart Value Score 25/100 (Grade F, Strong Sell).

What is the price target of Hyperfine Inc (HYPR)?

The analyst target price is $2.05, representing +9.6% upside from the current price of $1.87.

What is Hyperfine Inc's revenue?

TTM revenue is $13.56M.

Piotroski F-Score?

3/9 — weak financial health.

Altman Z-Score?

-4.95 — distress.

Company info

SectorHEALTHCARE

IndustryMEDICAL DEVICES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

hyperfine.io

Quick metrics

P/S ratio12.06x

ROE-79.00%

Beta1.06

50D MA$1.19

200D MA$1.20

Shares out0.08B

Float0.08B

Short ratio—

Avg volume0.6M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

HYPR vs LLY →HYPR vs JNJ →HYPR vs ABBV →Stock screener →